Maravai LifeSciences Holdings, Inc. (MRVI) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
16/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinMRVI / S&P 120.49% / 15.20% |
LoseMRVI / S&P -5.03% / 15.00% |
LoseMRVI / S&P -61.19% / 50.40% |
| 2026-Q10/3 |
LoseMRVI / S&P -12.92% / -4.33% |
LoseMRVI / S&P -15.35% / 11.30% |
LoseMRVI / S&P -37.72% / 27.70% |
| 2025-Q41/3 |
WinMRVI / S&P 13.24% / 2.65% |
LoseMRVI / S&P -28.34% / 9.00% |
LoseMRVI / S&P -11.76% / 13.40% |
| 2025-Q31/3 |
WinMRVI / S&P 19.09% / 8.12% |
LoseMRVI / S&P -30.47% / 4.61% |
LoseMRVI / S&P -48.78% / 13.45% |
| 2025-Q21/3 |
LoseMRVI / S&P 9.05% / 10.94% |
LoseMRVI / S&P -19.95% / 4.83% |
WinMRVI / S&P 32.67% / 10.63% |
| 2025-Q11/3 |
LoseMRVI / S&P -59.45% / -4.27% |
LoseMRVI / S&P -11.76% / 4.98% |
WinMRVI / S&P 15.15% / 10.57% |
| 2024-Q41/3 |
LoseMRVI / S&P -34.42% / 2.41% |
LoseMRVI / S&P -10.30% / 5.25% |
WinMRVI / S&P 13.33% / 6.15% |
| 2024-Q31/3 |
WinMRVI / S&P 16.06% / 5.89% |
LoseMRVI / S&P -34.03% / 5.89% |
LoseMRVI / S&P -920.00% / 6.11% |
| 2024-Q20/3 |
LoseMRVI / S&P -17.42% / 4.28% |
LoseMRVI / S&P -49.51% / 5.38% |
LoseMRVI / S&P -271.19% / 5.12% |
| 2024-Q11/3 |
WinMRVI / S&P 32.37% / 10.56% |
LoseMRVI / S&P -61.81% / 5.71% |
LoseMRVI / S&P -184.62% / 5.59% |
| 2023-Q40/3 |
LoseMRVI / S&P -34.50% / 11.69% |
LoseMRVI / S&P -67.28% / 6.81% |
LoseMRVI / S&P -153.89% / 7.78% |
| 2023-Q30/3 |
LoseMRVI / S&P -19.55% / -3.27% |
LoseMRVI / S&P -53.73% / 7.52% |
LoseMRVI / S&P -88.89% / -5.03% |
| 2023-Q20/3 |
LoseMRVI / S&P -11.28% / 8.74% |
LoseMRVI / S&P -40.90% / 9.50% |
LoseMRVI / S&P -68.95% / -8.57% |
| 2023-Q10/3 |
LoseMRVI / S&P -2.10% / 7.50% |
LoseMRVI / S&P -19.84% / 10.77% |
LoseMRVI / S&P -35.36% / -15.69% |
| 2022-Q41/3 |
LoseMRVI / S&P -43.95% / 7.56% |
LoseMRVI / S&P 10.48% / 11.88% |
WinMRVI / S&P 7.74% / -17.99% |
| 2022-Q31/3 |
LoseMRVI / S&P -10.14% / -4.88% |
WinMRVI / S&P 35.51% / 13.47% |
LoseMRVI / S&P -44.95% / -1.41% |
| 2022-Q21/3 |
LoseMRVI / S&P -19.45% / -16.10% |
WinMRVI / S&P 66.66% / 13.71% |
LoseMRVI / S&P -35.59% / 11.04% |
| 2022-Q11/3 |
LoseMRVI / S&P -15.82% / -4.60% |
WinMRVI / S&P 134.79% / 15.97% |
LoseMRVI / S&P -27.89% / 42.23% |
| 2021-Q41/3 |
LoseMRVI / S&P -14.63% / 11.03% |
WinMRVI / S&P 181.33% / 15.00% |
LoseMRVI / S&P -34.32% / 96.40% |
| 2021-Q31/3 |
WinMRVI / S&P 17.61% / 0.58% |
LoseMRVI / S&P MRVI unavailable / 10.77% |
LoseMRVI / S&P MRVI unavailable / 69.42% |
| 2021-Q21/3 |
WinMRVI / S&P 17.09% / 8.55% |
LoseMRVI / S&P MRVI unavailable / 6.58% |
LoseMRVI / S&P MRVI unavailable / 51.81% |
| 2021-Q11/3 |
WinMRVI / S&P 27.06% / 6.17% |
LoseMRVI / S&P MRVI unavailable / -1.06% |
LoseMRVI / S&P MRVI unavailable / 7.39% |
| 2020-Q40/3 |
LoseMRVI / S&P MRVI unavailable / 12.15% |
LoseMRVI / S&P MRVI unavailable / -3.72% |
LoseMRVI / S&P MRVI unavailable / -33.42% |
| 2020-Q30/3 |
LoseMRVI / S&P MRVI unavailable / 8.93% |
LoseMRVI / S&P MRVI unavailable / -2.04% |
LoseMRVI / S&P MRVI unavailable / -27.10% |
| 2020-Q20/3 |
LoseMRVI / S&P MRVI unavailable / 20.54% |
LoseMRVI / S&P MRVI unavailable / -0.46% |
LoseMRVI / S&P MRVI unavailable / -27.11% |
| 2020-Q10/3 |
LoseMRVI / S&P MRVI unavailable / -19.60% |
LoseMRVI / S&P MRVI unavailable / 3.47% |
LoseMRVI / S&P MRVI unavailable / -14.75% |
| 2019-Q40/3 |
LoseMRVI / S&P MRVI unavailable / 9.07% |
LoseMRVI / S&P MRVI unavailable / 5.36% |
LoseMRVI / S&P MRVI unavailable / 2.99% |
| 2019-Q30/3 |
LoseMRVI / S&P MRVI unavailable / 1.70% |
LoseMRVI / S&P MRVI unavailable / 5.02% |
LoseMRVI / S&P MRVI unavailable / 0.21% |
| 2019-Q20/3 |
LoseMRVI / S&P MRVI unavailable / 4.30% |
LoseMRVI / S&P MRVI unavailable / 6.64% |
LoseMRVI / S&P MRVI unavailable / 8.65% |
| 2019-Q10/3 |
LoseMRVI / S&P MRVI unavailable / 13.65% |
LoseMRVI / S&P MRVI unavailable / 8.12% |
LoseMRVI / S&P MRVI unavailable / 14.29% |
| 2018-Q40/3 |
LoseMRVI / S&P MRVI unavailable / -13.52% |
LoseMRVI / S&P MRVI unavailable / 9.05% |
LoseMRVI / S&P MRVI unavailable / 18.23% |
| 2018-Q30/3 |
LoseMRVI / S&P MRVI unavailable / 7.71% |
LoseMRVI / S&P MRVI unavailable / 10.21% |
LoseMRVI / S&P MRVI unavailable / 19.06% |
| 2018-Q20/3 |
LoseMRVI / S&P MRVI unavailable / 3.43% |
LoseMRVI / S&P MRVI unavailable / 9.03% |
LoseMRVI / S&P MRVI unavailable / 14.46% |
| 2018-Q10/3 |
LoseMRVI / S&P MRVI unavailable / -0.76% |
LoseMRVI / S&P MRVI unavailable / 7.68% |
LoseMRVI / S&P MRVI unavailable / 12.46% |
| 2017-Q40/3 |
LoseMRVI / S&P MRVI unavailable / 6.64% |
LoseMRVI / S&P MRVI unavailable / 7.03% |
LoseMRVI / S&P MRVI unavailable / 13.82% |
| 2017-Q30/3 |
LoseMRVI / S&P MRVI unavailable / 4.48% |
LoseMRVI / S&P MRVI unavailable / 5.68% |
LoseMRVI / S&P MRVI unavailable / 17.57% |
| 2017-Q20/3 |
LoseMRVI / S&P MRVI unavailable / 3.09% |
LoseMRVI / S&P MRVI unavailable / 4.83% |
LoseMRVI / S&P MRVI unavailable / 17.74% |
| 2017-Q10/3 |
LoseMRVI / S&P MRVI unavailable / 6.07% |
LoseMRVI / S&P MRVI unavailable / 3.67% |
LoseMRVI / S&P MRVI unavailable / 13.32% |
| 2016-Q40/3 |
LoseMRVI / S&P MRVI unavailable / 3.82% |
LoseMRVI / S&P MRVI unavailable / 2.09% |
LoseMRVI / S&P MRVI unavailable / 7.05% |
| 2016-Q30/3 |
LoseMRVI / S&P MRVI unavailable / 3.85% |
LoseMRVI / S&P MRVI unavailable / 0.20% |
LoseMRVI / S&P MRVI unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | MRVI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 245.87% | 20.78% |
| Annualized return | 245.87% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | MRVI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -85.57% | 83.14% |
| Annualized return | -32.10% | 12.86% |
10Y · 2020-11-20 to 2026-08-27
| Metric | MRVI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -71.96% | 319.30% |
| Annualized return | -11.94% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.